Who are the key players in North America Vascular Stent Market industry?

The key players include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Becton, Dickinson and Company (BD), and Cook Medical. These companies are renowned for innovation, strong clinical trial investments, and extensive product portfolios, contributing significantly to the competitive landscape of the vascular stent market in North America.

What is the North America Vascular Stent Market growth?

The North America Vascular Stent Market has witnessed robust growth in recent years, driven by technological advancements and rising cardiovascular disease rates. For example, Boston Scientific expanded its vascular stent lineup in 2023, fostering market growth. The market is expected to continue growing at a healthy compound annual growth rate.

Which segment accounted for the largest North America Vascular Stent Market share?

Coronary artery disease applications accounted for the largest market share in North America. This segment sees high demand as coronary stents are commonly used in procedures like angioplasty to open blocked arteries, driven by rising incidences of heart disease among the aging population.

What are the factors driving the North America Vascular Stent Market?

Key drivers include increasing prevalence of cardiovascular diseases, growing geriatric population, and technological innovations. For instance, Medtronic's introduction of next-generation drug-eluting stents has improved patient outcomes, expanding the adoption of vascular stent procedures and further stimulating market growth.

Which type accounted for the largest North America Vascular Stent Market share?

Drug-eluting stents accounted for the largest share in the North America vascular stent market. Their popularity is attributed to reduced restenosis rates and better long-term patient outcomes. Leading companies, like Abbott, continue innovating in this segment, driving adoption across hospitals and healthcare facilities.

Home Healthcare

North America Vascular Stent Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Vascular Stent Market
Brand: Bussiness Insights

North America Vascular Stent Market: by Type (Coronary Stents, Peripheral Stents, EVAR Stent Grafts, Others), Application (Coronary Artery Diseases, Peripheral Artery Diseases, Aneurysm, Others), Distribution Channels (Hospitals, Ambulatory Surgical Centers, Clinics, Others), Technology (Bare Metal Stents, Drug Eluting Stents, Bioabsorbable Stents, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20451

North America Vascular Stent Market (2025-2035) Analysis

The North America Vascular Stent Market is forecasted to grow significantly between 2025 and 2035, driven by the increasing prevalence of cardiovascular diseases, technological advancements in stent design, and the rising adoption of minimally invasive surgeries. The market encompasses various stent types including coronary, peripheral, and EVAR stent grafts, and finds application in treating coronary artery diseases, peripheral artery diseases, aneurysms, and others. The distribution channels include hospitals, ambulatory surgical centers, clinics, retail, and online pharmacies, with the U.S. leading market share in the region.

Latest Market Dynamics

Key Drivers

Rising incidence of cardiovascular diseases in North America, driving substantial demand for vascular stents. For example, Medtronic plc has expanded its stent portfolio catering to coronary and peripheral artery diseases, reflecting this underlying trend.

Rapid shift towards drug-eluting and bioabsorbable stents, offering enhanced clinical outcomes and reduced restenosis risks. Companies like Abbott Laboratories continue to launch next-generation drug-eluting stents with improved performance characteristics.
Adoption of advanced imaging and AI-driven diagnostic integration into stent procedures, enabling precision placement and improved patient success rates. Terumo Corporation has invested in digital health infrastructure supporting such tech enhancements.

Significant growth potential in underserved patient segments, such as those with complex vascular anatomies. Cook Medical is developing niche stent solutions to address these demands.
Expansion of stent usage in outpatient and ambulatory surgical settings. Cardinal Health reports rising stent sales through ambulatory surgery centers as patients seek quicker and less invasive treatment options.

Stringent regulatory requirements and reimbursement hurdles, leading to delayed product launches. Boston Scientific Corporation recently overcame U.S. FDA regulatory delays in new stent approvals.
Increasing market competition from low-cost manufacturers, particularly across the U.S. and Canada. MicroPort Scientific Corporation is actively expanding its presence with competitively priced stent solutions.

High procedural costs and limited access in certain rural North American regions. Endologix LLC is working to address affordability through targeted pricing strategies.
Incidences of post-operative complications, such as thrombosis and in-stent restenosis, which curb broader adoption. Biotronik SE & Co. KG is actively investing in research to minimize such risks.

In 2025, Coronary Stents dominate the North America vascular stent market, driven by high prevalence of coronary artery disease and continued innovation in drug-eluting and bioabsorbable technologies. Peripheral stents follow, supported by rising cases of peripheral artery diseases. EVAR stent grafts serve the aneurysm segment, while other niche types fill specific clinical gaps. The overall type composition indicates substantial ongoing demand for advanced stenting technologies targeting diverse arterial segments across the region.

The application breakdown in 2025 shows coronary artery diseases as the largest segment, corresponding with North America’s high incidence of heart conditions. Peripheral artery diseases also account for a sizeable market share, propelled by lifestyle factors and aging demographics. Aneurysm treatment segment steadily grows, while stroke and other niche vascular interventions represent a smaller, yet important component for specialized care. The application trend highlights the critical clinical role stents serve across multiple vascular disorders.

The North America vascular stent market is projected to grow from $6,100 million in 2020 to $11,900 million by 2035. The U.S. contributes the largest revenue share due to advanced healthcare infrastructure and rapid adoption of next-generation stenting technologies. Year-on-year growth reflects both rising cardiovascular disease burden and steady introduction of minimally invasive stenting options. Investments in digital diagnostics and procedural efficiency are anticipated to further boost the region’s vascular stent market value through 2035.

YoY growth in the North America vascular stent market exhibits stable, single-digit gains, averaging 4.2% in the 2020-2025 period and gradually moderating toward 3.2% by 2035 as the market matures. Early surges are driven by technological advancements and swift regulatory approvals, while competitive pressures and market saturation lead to steady, sustained expansion in the decade ahead.

The U.S. holds the lion’s share of the North America market at 83%, owing to its robust healthcare ecosystem and greater per capita expenditure on advanced treatments. Canada follows at 10%, benefitting from universal healthcare and increasing cardiovascular interventions. Mexico’s share stands at 7%, rapidly growing as healthcare access improves. This regional distribution reflects both mature and emerging opportunities for stent manufacturers across North America.

Abbott Laboratories leads the North American vascular stent market with significant investments in R&D and new product launches. Boston Scientific Corporation and Medtronic plc follow closely, leveraging their extensive distribution networks. Other established names include B. Braun and Terumo, who are expanding their influence through innovation and strategic partnerships. The top five players account for a majority share of the competitive landscape in 2025.

In 2025, hospitals remain the principal buyers of vascular stents, making up 59% of the market, thanks to high patient volumes and ability to handle complex cases. Ambulatory surgical centers are capturing a growing share at 18%, reflecting the trend toward outpatient procedures. Clinics and other buyers make up the remaining portion, advancing vascular stent penetration outside of major hospital systems as procedural simplicity rises.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	7600
Regions	US, Canada, Mexico
Segments	Coronary Stents, Peripheral Stents, EVAR Stent Grafts, Drug Eluting Stents, Bare Metal Stents, Others; Coronary Artery Diseases, Peripheral Artery Diseases, Aneurysm, Stroke, Carotid Artery Disease, Others
Players	Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, B. Braun Melsungen AG, Terumo Corporation, Cook Medical, Cardinal Health, C.R. Bard (Becton, Dickinson and Company), MicroPort Scientific Corporation, Biotronik SE & Co. KG, Endologix LLC, Gore Medical, Cordis (Cardinal Health), Lombard Medical, Others

June 2024: Abbott Laboratories announced the launch of its new-generation drug eluting stent, delivering enhanced outcomes for complex coronary lesions.
July 2024: Medtronic plc received FDA approval for its next-gen self-expanding peripheral stent, expanding access for critical limb ischemia patients.
August 2024: Boston Scientific Corporation completed the acquisition of a digital health startup to improve stent-patient follow-up care using AI-powered platforms.
September 2024: Terumo Corporation expanded its North America distribution network, focusing on balloon-expandable and bioabsorbable stent segments.
October 2024: Cook Medical reported successful completion of a large-scale clinical trial for its latest EVAR stent graft technology, with publication of favorable results.

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

North America Vascular Stent Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Vascular Stent Market (2025-2035) Analysis

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America Vascular Stent Market Share (%) by Type, 2025

North America Vascular Stent Market Share (%) by Application, 2025

North America Vascular Stent Market Revenue (USD Million), 2020-2035

North America Vascular Stent Market YoY Growth (%), 2020-2035

North America Vascular Stent Market Share (%) by Region, 2025

North America Vascular Stent Market Major Players' Share (%), 2025

North America Vascular Stent Market Buyers Share (%), 2025

Study Coverage

Key Recent Developments

Frequently asked questions